Advocacy in Neurology
Oxford University Press (Verlag)
978-0-19-879603-9 (ISBN)
Advocacy in Neurology provides an integrated approach to the concept of advocacy in neurology. Structured in five sections, the book begins by explaining the term "advocacy" in general before elaborating on the areas of interest within neurology. The text goes on to offer concrete strategies and tools for clinicians to deploy advocacy in their daily work, and then discusses specific neurological diseases to point out and explain where advocacy is, or could be, beneficial. The book ends with an outlook, presentation of results, and an ending conclusion.
Advocacy in Neurology offers a practical perspective on advocacy activities in neurology, aiming to show when and why they are important for neurology.
Professor Wolfgang Grisold is a Neurologist at Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria. His main research interests are in general neurology , neuro-oncology, palliative care, and neuromuscular disease. He has experience in hospital/institutional neurology and also general neurology and neuromuscular disease in private/office settings. Associate Professor Walter Struhal is a Neurologist and Chair of the Department of Neurology at University Clinic Tulln, Karl Landsteiner University of Health Sciences, Tulln, Austria. His main research interests are in neurointensive care medicine, neurodegenerative diseases, and the autonomic nervous system, as well as medical postgraduate education. Dr Thomas Grisold is a Research and Teaching Associate at Vienna University of Economics and Business, Vienna, Austria and he is studying a PhD in business and management. His main research interests are around the concept of organizational unlearning which refers to periods when organizations intentionally seek to get rid of established knowledge structures in order to create and implement new ones. Having a background in cognitive science, he aims to complement management research with interdisciplinary perspectives from neuroscience and philosophy.
Section 1: What is advocacy?
1: Wolfgang Grisold, Walter Struhal, and Thomas Grisold: What is advocacy?
2: Thomas Grisold and Oliver Lukitsch: Taking an epistemological perspective on advocacy
3: Wolfgang Maderthaner and Wolfgang Grisold: Advocacy in history and culture
4: Jan J. Heimans: Ethical issues in neurology
5: Tissa Wijeratne, Essie Low, and Christopher Neil: Physician, autonomy, and pharmaceutical industry
6: Mohammad Wasay: Advocacy, campaigning , lobbying: Good or bad?
Section 2: Why is advocacy needed?
7: Wolfgang Grisold: Knowledge and science is not enough
8: Mohammad Wasay: Perspectives on advocacy of medical doctors
9: Hanneke Zwinkels: Advocacy and the perspective of (neurology) nursing
10: Helen Bulbeck: Patient and caregiver advocacy
11: Françoise Van Hemelryck: Patient involvement in European cancer societies: The example of ECCO - the European CanCer Organization
12: Mustapha El Alaoui Faris: Advocacy for neurology in migrants
13: Apoorva Pauranik: Advocacy for neurology: Local, regional, national
14: Raad Shakir: Advocacy in the international arena
15: Jes Olesen and Frédéric Destrebecq: Working with others, the lesson of the European Brain Council
16: Richard Pichler: SOS children's villages: Re-discovering advocacy to increase relevance and impact. A high level case study
Section 3: What tools can be used for advocacy?
17: Walter Struhal and Thomas Grisold: Project management techniques for advocates
18: Wolfgang Grisold, Anna Klicpera, and Thomas Grisold: International advocacy: Case studies and lessons learnt
19: Birgit Kofler: Using PR tools for advocacy
Section 4: Advocacy in different neurological diseases
20: Tissa Wijeratne, Sheila Crewther, and David Crewther: Advocacy for stroke
21: Christoph Thalheim: Two decades of patient advocacy in Multiple Sclerosis: The success story of the European MS Platform
22: Albert C. Ludolph: Advocacy in amyotrophic lateral sclerosis
23: Elaine C. Jones and John D. England: Neuromuscular disorders and advocacy
24: Francesca Mancini and Carlo Colosimo: Advocacy for movement disorders
25: Riccardo Soffietti, Christine Marosi, Roberta Rudà, and Wolfgang Grisold: Advocacy for brain tumours
26: Gorazd B. Stokin: Advocacy in dementia
27: Fritz Zimprich: Advocating for orphan diseases in neurology
28: David Oliver: Palliative care
29: Jules C. Beal and Solomon L. Moshe: Advocacy for epilepsy: From the shadows to centre stage: Stand up for epilepsy
30: Timothy J. Steiner and Jes Olesen: Advocacy for patients with headache
31: Ligia Onofrei and A. Gordon Smith: Advocacy for patients with neuropathic pain
Section 5: Outlook, follow-up, results, ending, conclusion, and debriefing
32: Wolfgang Grisold and Thomas Grisold: Continuation or ending and 'debriefing'
33: Wolfgang Grisold, Walter Struhal, and Thomas Grisold: Results, outlook, and goals of this book
Erscheinungsdatum | 21.01.2019 |
---|---|
Verlagsort | Oxford |
Sprache | englisch |
Maße | 156 x 234 mm |
Gewicht | 596 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie |
ISBN-10 | 0-19-879603-X / 019879603X |
ISBN-13 | 978-0-19-879603-9 / 9780198796039 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich